April 7, 2023 - ALS Association Research Partnership and more news...

Published: April 7, 2023

April 7, 2023

New Partnership Will Advance Focused Ultrasound in ALS Diagnosis and Treatment

The Foundation has partnered with The ALS Association to advance transformational treatments for people with amyotrophic lateral sclerosis (ALS).
Also known as Lou Gehrig’s disease, ALS is a progressive neurodegenerative disease for which there is no cure.
A formal request for applications (RFA) will be issued later this year, with $1 million in research funding available.

Pilot Returns to the Sky After Focused Ultrasound Treatment for Essential Tremor

Paul Lyman standing next to his airplane

At age 74, Paul Lyman sold his Cessna 182 airplane after deciding to seek treatment for his essential tremor symptoms.
Last April, he traveled 400 miles to have focused ultrasound treatment at the University of Utah.
Learn how the treatment changed his life and got him back in the cockpit.

First Patient Treated in HistoSonics’ Kidney Tumor Trial

A new clinical trial has begun in the UK investigating histotripsy for the treatment of primary kidney tumors.
HistoSonics’ Edison platform uses histotripsy to noninvasively and mechanically destroy tissue.
The trial is named after the late Charles Cain, PhD, co-inventor of histotripsy and co-founder of HistoSonics.

Initiative Launched to Promote Machine Learning in Focused Ultrasound

Rick Hamilton Machine Learning and the Future of Focused Ultrasound Technology

Machine learning (ML), a branch of artificial intelligence, is transforming healthcare delivery.
Rick Hamilton, the Foundation’s chief technology officer, explains why now is the time to drive adoption of ML in focused ultrasound.
A new webpage shares more about this new initiative and offers ways to get involved.

Learn More

Advocacy Partner Highlights Government Bioscience Funding Opportunities

The Foundation has partnered with G2G Consulting to provide monthly reports on government bioscience grants – the GBG Report.
This effort is part of an ongoing partnership to drive impact for the focused ultrasound community through advocacy.

Read the Latest GBG Report

Forwarded this email by a friend? Sign up to receive these emails here.

“There is a clear unmet clinical need for patients with ALS, and this partnership will provide critical disease-specific expertise to the focused ultrasound community, exploring a totally new approach to facilitate drug, gene, and stem cell delivery.”

‒ Foundation Chairman Neal F. Kassell, MD

Do you have news for our newsletter? Tell us about it!

April 7, 2023 - ALS Association Research Partnership and more news...

Contact

Terms of Use